John Freund
Director/Board Member at SI-BONE, INC.
Net worth: 4 M $ as of 31/03/2024
Profile
John Gordon Freund is the founder of Healthcare Group, Intuitive Surgical, Inc., Skyline Management LLC, and Arixa Pharmaceuticals, Inc. (founded in 1982, 1995, 1997, and 2016 respectively).
He is also the founder of Triad Therapeutics, Inc. Dr. Freund's current jobs include Director positions at Advion BioSciences, Inc., Crescendo Bioscience LLC, The Growth Fund of America, Medivance, Inc., Smallcap World Fund, and Senior Advisor at McNally Capital LLC.
Dr. Freund's former jobs include Chairman at XenoPort, Inc., Managing Director-Private Equity Group at Chancellor Capital Management, Inc., Managing Director at Citigroup, Inc., Director at Tolerx, Inc., Director at Hansen Medical, Inc., Independent Director at Proteon Therapeutics, Inc., Director at MAP Pharmaceuticals LLC, Director at Sirtris Pharmaceuticals, Inc., Director at Calypso Medical Technologies, Inc., Independent Director at MAKO Surgical Corp., Director at Satiety, Inc., Independent Director at Concert Pharmaceuticals, Inc., Independent Director at Tetraphase Pharmaceuticals, Inc., Director at Advion, Inc., Director at Eurofins DiscoverX Corp., Inc., Head-Healthcare Group at Morgan Stanley & Co. LLC, and General Partner at Morgan Stanley Venture Partners.
Dr. Freund received a doctorate from Harvard Medical School in 1980, an MBA from Harvard Business School in 1982, and an undergraduate degree from Harvard College in 1975.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
SI-BONE, INC.
0.32% | 09/08/2023 | 129,734 ( 0.32% ) | 2 M $ | 31/03/2024 |
27/03/2024 | 45,666 ( 0.14% ) | 2 M $ | 31/03/2024 | |
SUTRO BIOPHARMA, INC.
0.09% | 08/06/2023 | 56,327 ( 0.09% ) | 318 248 $ | 31/03/2024 |
John Freund active positions
Companies | Position | Start |
---|---|---|
SI-BONE, INC. | Director/Board Member | 01/01/2013 |
COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 01/02/2014 |
SUTRO BIOPHARMA, INC. | Director/Board Member | 01/02/2014 |
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Director/Board Member | - |
Smallcap World Fund | Director/Board Member | - |
The Growth Fund of America | Director/Board Member | - |
American Funds Fundamental Investors | Director/Board Member | - |
McNally Capital LLC
McNally Capital LLC Investment ManagersFinance McNally Capital LLC (McNally Capital) is a venture capital firm founded in 2008 by Ward S. McNally and John P. Rompon. The firm is headquartered in Chicago, Illinois. | Consultant / Advisor | 01/06/2017 |
Advion BioSciences, Inc.
Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | Director/Board Member | - |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of John Freund
Companies | Position | End |
---|---|---|
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of John Freund
Harvard Medical School | Doctorate Degree |
Harvard Business School | Masters Business Admin |
Harvard College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
INTUITIVE SURGICAL, INC. | Health Technology |
CITIGROUP INC. | Finance |
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
SUTRO BIOPHARMA, INC. | Health Technology |
SI-BONE, INC. | Health Technology |
Private companies | 29 |
---|---|
Acuson Corp.
Acuson Corp. Medical SpecialtiesHealth Technology Acuson Corp. used to design, manufacture and market premium quality medical diagnostic ultrasound imaging systems and image management products. The company was headquartered in Mountain View, CA | Health Technology |
Chancellor Capital Management, Inc. | Finance |
Advion BioSciences, Inc.
Advion BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Advion BioSciences, Inc. provides bioanalytical contract services to the pharmaceutical industry. Its clients include academic institutions, biotechnology, and pharmaceutical companies. Advion is the partner of choice for pharmaceutical, biotechnology, and research customers requiring scientific excellence in their bioanalytical services and microfluidic chemistry systems. Its deep scientific expertise drives a product and services portfolio characterized by exceptional data quality, flexibility, speed, and regulatory compliance. Advion's excellence in method development provides a tremendous advantage in establishing reliable bioanalytical assays in a timely and cost-effective manner. Its expertise in technology development provides more information, better synthesis and mass analysis, higher yields, and substantially greater throughput. The company was founded in 1993 and is located in Ithaca, NY. | Commercial Services |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
Hansen Medical, Inc.
Hansen Medical, Inc. Medical SpecialtiesHealth Technology Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for positioning, manipulation, and stable control of catheters and catheter-based technologies. It offers Sensei Robotic Catheter System which allows physicians to instinctively navigate flexible catheters with stability and control in interventional procedures within the atria heart chambers. The company was founded by Frederic H. Moll, Daniel T. Wallace, Marvin J. Slepian, and Robert G. Younge on November 18, 2002 and is headquartered in Redwood City, CA. | Health Technology |
Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
Sirtris Pharmaceuticals, Inc.
Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sirtris Pharmaceuticals, Inc., a GSK company, is developing small molecule drugs that target the sirtuins, a family of seven enzymes associated with diseases of aging. Modulation of these enzymes offers the promise of drug discovery in multiple therapeutic areas. Sirtris was one of the pharmaceutical companies focused on the sirtuin platform and remains the innovative drug discovery. Preclinical research indicates that the sirtuins play important roles in pathways for multiple diseases of aging, including Type 2 Diabetes, as well as neurodegenerative, cardiovascular and inflammatory diseases. Sirtris researchers are working to translate this research into a potential new class of pharmaceuticals to treat diseases of aging, offering the ability for people to live longer, healthier lives. Sirtris has focused on developing many novel small molecule activators of SIRT1, the most studied member of the sirtuin family. These new chemical entities or NCEs are novel compounds that are chemically unrelated to resveratrol, a naturally occurring compound that was used as an early proof-of-concept for SIRT1 activation. Besides being structurally differentiated from resveratrol, the NCEs are more specific for the target SIRT1 and have improved drug-like properties. The company has completed several early stage translational clinical studies with the first generation NCEs and has several active clinical trials under way. Sirtris operates as an independent Discovery Performance Unit (DPU) within GSK and is located in Technology Square, Cambridge, Mass. Sirtris' culture mixes scientific curiosity with a dynamic, fast-paced environment, resembling its biotech roots while harnessing all of GSK's broad discovery, development, and commercialization capabilities. The company was founded in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Calypso Medical Technologies, Inc.
Calypso Medical Technologies, Inc. Medical/Nursing ServicesHealth Services Calypso Medical Technologies, Inc. provided radiation therapy and medical services. The company was founded by Eric R. Meier, Alfred G. Merriweather and Steve Tallman in 1999 and was headquartered in Seattle, WA. | Health Services |
MAKO Surgical Corp.
MAKO Surgical Corp. Medical SpecialtiesHealth Technology MAKO Surgical Corp. is a medical device company, which develops and markets advanced robotic arm solution, joint specific applications for the knee, hip and orthopedic implants for orthopedic procedures. It also provides RIO robotic arm interactive orthopedic system, including a tactile robotic arm utilizing an integrated bone cutting instrument and a patient specific visualization component. The company was founded by Maurice R. Ferre and Rony A. Abovitz in November 2004 and is headquartered in Fort Lauderdale, FL. | Health Technology |
Keeley Funds, Inc. | Miscellaneous |
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
Satiety, Inc.
Satiety, Inc. Medical SpecialtiesHealth Technology Satiety, Inc. was a medical device manufacturing company. It produced and marketed less invasive devices for the treatment of obesity. The company was founded in 2000 through a collaboration of medical device incubators Thomas Fogarty Engineering and The Foundry and was headquartered in Palo Alto, CA. | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
The Growth Fund of America | Miscellaneous |
Advion, Inc.
Advion, Inc. Medical SpecialtiesHealth Technology Advion, Inc. engages in the development, manufacture, and support mass spectrometers, chip-based ion sources, microfluidic flow chemistry systems, and consumables for life science and related industries. Its products include expression CMS (compact mass spectrometer), Plate Express, SOLATION ICP-MS (inductively coupled plasma mass spectrometry), Triversa NanoMate, ASAP (atmospheric esolids analysis probe), and Touch Express. The company was founded by Jack D. Henion and Thomas R. Kurz in 1993 and is headquartered in Ithaca, NY. | Health Technology |
American Funds Fundamental Investors | Miscellaneous |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
Medivance, Inc.
Medivance, Inc. Medical SpecialtiesHealth Technology Medivance, Inc. develops, manufactures and markets therapeutic temperature management products. The company was founded in 1998 and is headquartered in Louisville, CO. | Health Technology |
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | Finance |
Morgan Stanley Venture Partners
Morgan Stanley Venture Partners Investment ManagersFinance Morgan Stanley Venture Partners (MSVP) is a venture capital firm subsidiary of Morgan Stanley Investment Management Merchant Banking, which is ultimately owned by Morgan Stanley (NYSE: MWD) founded in 1986.The firm is headquartered in New York. | Finance |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Triad Therapeutics, Inc.
Triad Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Triad Therapeutics was founded in April 1998 as Triad Biotechnology by scientists Stephen Coutts and Dan Sem and venture capitalist John Freund. In June 1999, Lin Yu and Rick Jack joined the Company as co-founders Triad Therapeutics, Inc. developed and manufactured drugs. It focused on generating highly potent and specific drug candidates by integrating structural biology, medicinal chemistry to accelerate discovery and development of potent, small molecule drugs. The company also provided high-affinity, nanomolar chemical lead compounds to pharmaceutical and biotechnology industries. It was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Health Technology |
Healthcare Group
Healthcare Group Miscellaneous Commercial ServicesCommercial Services Healthcare Group, founded by John Gordon Freund, is a legal firm that specializes in providing legal advice to medical practices. The firm is based in Plymouth Meeting, PA. The private company offers a range of services including drafting new doctor employment agreements, advising on salary, bonus, benefits, and buy-in provisions, developing buy-in models, creating partnership agreements, advising on corporate counsel, sale or merger, hospital contracts, government regulations and compliance, practice valuation, and retirement plans and employee benefits. The firm has over 40 years of experience in the industry and has helped numerous medical practices with their legal needs. | Commercial Services |
Smallcap World Fund | Miscellaneous |
McNally Capital LLC
McNally Capital LLC Investment ManagersFinance McNally Capital LLC (McNally Capital) is a venture capital firm founded in 2008 by Ward S. McNally and John P. Rompon. The firm is headquartered in Chicago, Illinois. | Finance |
Arixa Pharmaceuticals, Inc.
Arixa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arixa Pharmaceuticals, Inc. engages in the development of oral antibiotics for resistant gram-negative infections. The company was founded by Eric Gordon, John Gordon Freund, and Joaquim Trias in 2016 and is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- John Freund